Ritanserin, a selective 5-HT2/1C antagonist, and negative symptoms in schizophrenia. A placebo-controlled double-blind trial
(Q72659567)
scientific article published on 01 October 1993
scientific article published on 01 October 1993
Language:
Current Data About
Ritanserin, a selective 5-HT2/1C antagonist, and negative symptoms in schizophrenia. A placebo-controlled double-blind trial
other details
description | scientific article published on 01 October 1993 |
External Links
(P356) |
10.1192/BJP.163.4.451
|
(P698) |
7902766
|